FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drugFederal regulators are putting off a decision on Eli Lillyโs potential Alzheimerโs treatment with an unusual request to have an advisory committee examine the drug.
After US approval, Japan OKs Leqembi, its first Alzheimer's drug, developed by Eisai and BiogenJapanโs health ministry has approved Leqembi, a drug for Alzheimerโs decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Eli Lilly says experimental drug slows Alzheimer's worseningEli Lilly and Co. says its experimental Alzheimer's drug appears to slow worsening of the mind-robbing disease.